Suppr超能文献

腺癌食管手术的发展:二十年对比

Developments in esophageal surgery for adenocarcinoma: a comparison of two decades.

作者信息

Gockel I, Sultanov F S, Domeyer M, Goenner U, Junginger Th

机构信息

Department of General and Abdominal Surgery, Johannes Gutenberg-University of Mainz, Mainz, Germany.

出版信息

BMC Cancer. 2007 Jun 29;7:114. doi: 10.1186/1471-2407-7-114.

Abstract

BACKGROUND

The objective of this study was to examine outcomes in patients undergoing esophageal resection for adenocarcinoma at our institution during a 20-year period and, in particular, to address temporal trends in long-term survival.

METHODS

Out of 470 patients who underwent esophagectomy for malignancy between September 1985 and September 2005, a total number of 175 patients presented with esophageal adenocarcinoma. Patients enrolled in this study included AEG (adenocarcinoma of the esophagogastric junction) type I tumors only. Time trends were studied comparing two decades, 9/1985 to 9/1995 (DI) and 10/1995 to 9/2005 (DII).

RESULTS

The overall survival was significantly more favourable in patients undergoing esophageal resection for adenocarcinoma in the recent time period (DII, 10/1995 to 9/2005) as compared to the early time period (DI, 9/1985 to 9/1995) (log rank test: p = 0.0329). Significant differences in the recent decade were seen based on lower ASA-classifications, earlier tumor stages, and the operative procedure with a higher frequency of transhiatal resections (p < 0.05). 30-day mortality improved from 8.3% to 3.1% during the 20-year time-interval, thus without statistical significance.

CONCLUSION

Based on our experience, overall survival is improving over time for adenocarcinoma of the esophagus. Factors that may play an important role in this trend include early diagnosis and improved patient selection through better preoperative staging, improved surgical technique with a tailored approach carefully evaluated by physiologic patient status, comorbidity and tumor extent.

摘要

背景

本研究的目的是调查我院20年间接受食管癌切除术治疗腺癌患者的预后情况,特别是探讨长期生存的时间趋势。

方法

1985年9月至2005年9月期间,470例因恶性肿瘤接受食管切除术的患者中,共有175例为食管腺癌患者。本研究纳入的患者仅包括I型食管胃交界腺癌(AEG)。通过比较两个十年,即1985年9月至1995年9月(第一时期)和1995年10月至2005年9月(第二时期),研究时间趋势。

结果

与早期(第一时期,1985年9月至1995年9月)相比,近期(第二时期,1995年10月至2005年9月)接受食管腺癌切除术患者的总生存率显著更高(对数秩检验:p = 0.0329)。基于较低的美国麻醉医师协会(ASA)分级、更早的肿瘤分期以及经裂孔切除术频率更高的手术方式,在最近十年观察到显著差异(p < 0.05)。在20年时间间隔内,30天死亡率从8.3%降至3.1%,但无统计学意义。

结论

根据我们的经验,食管腺癌患者的总生存率随时间推移有所提高。在这一趋势中可能起重要作用的因素包括早期诊断、通过更好的术前分期改善患者选择、根据患者生理状态、合并症和肿瘤范围精心评估后采用的改良手术技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9729/1914077/70388171a814/1471-2407-7-114-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验